0001104659-23-079118.txt : 20230707
0001104659-23-079118.hdr.sgml : 20230707
20230707160731
ACCESSION NUMBER: 0001104659-23-079118
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230705
FILED AS OF DATE: 20230707
DATE AS OF CHANGE: 20230707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZELEFSKY MICHAEL J
CENTRAL INDEX KEY: 0001266801
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38191
FILM NUMBER: 231076856
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MUSTANG BIO, INC.
CENTRAL INDEX KEY: 0001680048
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473828760
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 377 PLANTATION STREET
CITY: WORCESTER
STATE: MA
ZIP: 01605
BUSINESS PHONE: 7816524500
MAIL ADDRESS:
STREET 1: 377 PLANTATION STREET
CITY: WORCESTER
STATE: MA
ZIP: 01605
4
1
tm2320790-6_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-07-05
0
0001680048
MUSTANG BIO, INC.
MBIO
0001266801
ZELEFSKY MICHAEL J
377 PLANTATION STREET
WORCESTER
MA
01605
1
0
0
0
0
COMMON STOCK, PAR VALUE $0.0001
2023-07-05
4
A
0
7246
0.0000
A
18970
D
The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date.
Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Includes restricted share units, which vest over various time periods.
/s/ Matthew Wein, Attorney-in-Fact
2023-07-07